UBS stock eyes cautious recovery after Credit Suisse merger gains
UBS Group AG remains a key focus for investors across Germany, Austria, and Switzerland. The bank's financial strength has grown since its takeover of Credit Suisse in March 2023, though its stock price has faced recent declines. Analysts now see potential for a modest recovery in the coming months.
The bank's shares currently trade at around 32.67 €, down from a 52-week high of 41.99 €. Over the past three months, the stock has dropped by 11.17%, with shorter-term losses of 8.38% in one month and 3.54% in a week. Despite this downturn, projections suggest a rebound, with a target of $39.22 by mid-March—an increase of 6.17%.
The Credit Suisse merger has significantly boosted UBS's wealth management division, pushing assets under management beyond $5 trillion. This expansion, combined with a strong Common Equity Tier 1 (CET1) ratio of over 14%, leaves the bank well above regulatory requirements. Such stability supports capital returns and an attractive dividend yield, appealing to investors in uncertain markets.
Looking ahead, the full integration of Credit Suisse by the end of 2025 is expected to further strengthen UBS's balance sheet. Analysts forecast a year-end target of $40.61 for 2026, marking a near 10% rise from current levels.
UBS Group AG's stock shows signs of a gradual recovery, despite recent declines. With a solid financial foundation and ongoing integration benefits, the bank remains a stable option for investors in the DACH region. The next quarter could see shares climb toward $40, reflecting cautious optimism in the market.
